Clinical Trial Update: A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100) [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating avelumab plus axitinib in advanced renal cell cancer has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Avelumab (avelumab)
• Axitinib (Axitinib)

Snippet

Sponsor: Pfizer | Conditions: Renal Cell Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-06-21